These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series. Bobillo S, Abrisqueta P, Sánchez-González B, Giné E, Romero S, Alcoceba M, González-Barca E, González de Villambrosía S, Sancho JM, Gómez P, Bento L, Montoro J, Montes S, López A, Bosch F, Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO cooperative group). Ann Hematol; 2018 Dec; 97(12):2417-2424. PubMed ID: 30116871 [Abstract] [Full Text] [Related]
33. A 5-drug regimen maximizing the dose of cyclophosphamide is effective therapy for adult Burkitt or Burkitt-like lymphomas. Kujawski LA, Longo WL, Williams EC, Turman NJ, Brandt N, Mosher DF, Eickhoff JC, Kahl BS. Cancer Invest; 2007 Mar; 25(2):87-93. PubMed ID: 17453819 [Abstract] [Full Text] [Related]
37. Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment. Colebunders R, Dohmen S, Van de Velde A, Pelgrom J, Hermans P. Acta Clin Belg; 2001 Jan; 56(5):321-2. PubMed ID: 11770227 [No Abstract] [Full Text] [Related]
38. Fourth biannual report of the Cochrane Haematological Malignancies Group. Kober T, Hülsewede H, Bohlius J, Engert A. J Natl Cancer Inst; 2006 Apr 19; 98(8):E1. PubMed ID: 16622111 [No Abstract] [Full Text] [Related]